Randomized controlled trial of oral glutathione supplementation on body stores of glutathione. Eur J Nutr
Gastrointestinal effects: the main titration bottleneck Nausea, diarrhea, constipation, and vomiting run around 40 to 44% overall, dose-dependent in how many people report them but mild-dominant in severity: severe events stay at or below about 1.7% in any category even at the top dose. In the obesity program the by-dose rates run nausea 25/29/28%, diarrhea 19/21/23%, and vomiting 8/11/13% at 5/10/15 mg. They concentrate during escalation and ease with time on a held dose
Consultation: Your appointment begins with a brief health check with our clinician to review your medical history and ensure the formulation is perfectly suited to your needs
Furthermore, if there are any ongoing infections or immune-related issues contributing to the overall health decline, immunity-boosting IV therapy might be an effective solution to explore before starting peptide therapy
By reducing oxidative stress and improving gene regulation, Epitalon may help protect neurons, preserve synaptic integrity, and delay cognitive decline associated with aging
